Yue-Long Xu
Yue-Long Xu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Ji-Wei Li
Department of Neurology, Linyi Central Hospital, Linyi 276400, Shandong Province, People’s Republic of China
1 shared publication- Jianping Xiang
ArteryFlow Technology Co., Ltd., Hangzhou, China
1 shared publication - Jinyu Xiang
Departments of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, 264000, People’s Republic of China
1 shared publication - Jiwei Li
Department of Neurology, Yishui Central Hospital, Shandong, China
1 shared publication - Lan Zhou
Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing, China
1 shared publication - Li Li
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
1 shared publication
Latest Publications
- Open Access
- 1 April 2019
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 15, 1015-1029
Aldehyde dehydrogenase 2 rs671G>A polymorphism and ischemic stroke risk in Chinese population: a meta-analysis
Introduction: Recently, molecular epidemiological studies have suggested that aldehyde dehydrogenase 2 (ALDH2) rs671 G>A polymorphism may be a risk factor for ischemic stroke (IS). However, the results reported have not been consistent. Methods: We conducted the meta-analysis to explore the precise association between ALDH2 rs671 G>A polymorphism and IS risk. Five online databases were searched and the relative studies were reviewed from inception to October 1, 2018. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were calculated in each genetic model of the general and subgroup. Furthermore, the heterogeneity, accumulative analyses, sensitivity analyses and publication bias were calculated simultaneously. Results: Overall, nine case-control studies involving 6,129 subjects were included in this meta-analysis. All studies were focused on the Chinese population and some significant associations were found between ALDH2 rs671 G>A polymorphism and IS risk (A vs G: OR=1.29, 95% CI=1.01–1.65, P=0.04, I2=78.2%; AA vs GG: OR=1.86, 95% CI=1.27–2.21, P2=11.3%; AA vs GG + GA: OR=1.67, 95% CI=1.27–2.19, PA polymorphism may play an important role in the occurrence of IS by reducing the activity of ALDH2 and interfering with the metabolic processes involving acetaldehyde.
- 1 April 2019
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 15, 1015-1029
Open AccessAldehyde dehydrogenase 2 rs671G>A polymorphism and ischemic stroke risk in Chinese population: a meta-analysis
Introduction: Recently, molecular epidemiological studies have suggested that aldehyde dehydrogenase 2 (ALDH2) rs671 G>A polymorphism may be a risk factor for ischemic stroke (IS). However, the results reported have not been consistent. Methods: We conducted the meta-analysis to explore the precise association between ALDH2 rs671 G>A polymorphism and IS risk. Five online databases were searched and the relative studies were reviewed from inception to October 1, 2018. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were calculated in each genetic model of the general and subgroup. Furthermore, the heterogeneity, accumulative analyses, sensitivity analyses and publication bias were calculated simultaneously. Results: Overall, nine case-control studies involving 6,129 subjects were included in this meta-analysis. All studies were focused on the Chinese population and some significant associations were found between ALDH2 rs671 G>A polymorphism and IS risk (A vs G: OR=1.29, 95% CI=1.01–1.65, P=0.04, I2=78.2%; AA vs GG: OR=1.86, 95% CI=1.27–2.21, P2=11.3%; AA vs GG + GA: OR=1.67, 95% CI=1.27–2.19, PA polymorphism may play an important role in the occurrence of IS by reducing the activity of ALDH2 and interfering with the metabolic processes involving acetaldehyde.
- Open Access
- 1 January 2016
- Published by XMLink in Journal of Korean Medical Science
- Vol. 31 (5) , 688-694
Silencing of Long Non-Coding RNA MALAT1 Promotes Apoptosis of Glioma Cells
Xiang J, et al. J Korean Med Sci. 2016 May;31(5):688-694. https://doi.org/10.3346/jkms.2016.31.5.688
- 1 January 2016
- Published by XMLink in Journal of Korean Medical Science
- Vol. 31 (5) , 688-694
Open AccessSilencing of Long Non-Coding RNA MALAT1 Promotes Apoptosis of Glioma Cells
Xiang J, et al. J Korean Med Sci. 2016 May;31(5):688-694. https://doi.org/10.3346/jkms.2016.31.5.688